Condition category
Cancer
Date applied
20/03/2006
Date assigned
18/04/2006
Last edited
20/04/2006
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Larry Librach

ORCID ID

Contact details

600 University Avenue
Toronto
M5G 1X5
Canada

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

PHCTF-G03-02803

Study information

Scientific title

Acronym

TIPS

Study hypothesis

The number of hospital days for eligible palliative patients would be decreased by at least 30% for those patients who receive telehomecare versus those who receive standard care in the community

Ethics approval

Approved by Mount Sinai Research Ethics Board, 8th September 2004, reference number: 04-0187-E

Study design

Randomized controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Treatment

Patient information sheet

Condition

Palliative oncology

Intervention

Intervention: telehomecare equipment including videophones, blood pressure measurement devices, pulse oximeters, and stethoscopes placed in patient homes, operated remotely by registered nurses, physicians, and case managers. Face to face visits also provided.

Control: standard homecare.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Utilization of acute care services

Secondary outcome measures

1. Quality of life (patient and family caregiver)
2. Pain and symptom management (patient)
3. General health status (family caregiver)
4. Satisfaction (patient, family caregiver, health care professional)

Overall trial start date

18/10/2004

Overall trial end date

30/04/2006

Reason abandoned

Eligibility

Participant inclusion criteria

1. Newly referred to palliative care
2. Cancer diagnosis
3. Over 18 years of age
4. English speaking
5. Someone in the home able to operate the telehomecare equipment
6. Three pronged outlet in home
7. Digital Subscriber Line provision possible

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

300

Participant exclusion criteria

Life expectancy <2 weeks upon referral as evidenced by a palliative performance scale (PPS) score of 20% or less

Recruitment start date

18/10/2004

Recruitment end date

30/04/2006

Locations

Countries of recruitment

Canada

Trial participating centre

600 University Avenue
Toronto
M5G 1X5
Canada

Sponsor information

Organisation

Primary Health Care Transition Fund (Canada)

Sponsor details

5700 Yonge Street
Third Floor
North York
M2M 4K5
Canada
+1 416 327 7543
Jeffrey.Kwok@moh.gov.on.ca

Sponsor type

Government

Website

http://www.hc-sc.gc.ca/hcs-sss/prim/phctf-fassp/index_e.html

Funders

Funder type

Government

Funder name

Primary Health Care Transition Fund PHCTF-G03-02803

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes